Omega Healthcare Investors (NYSE:OHI) Posts Earnings Results, Beats Expectations By $0.01 EPS

Omega Healthcare Investors (NYSE:OHI) released its quarterly earnings results on Wednesday. The real estate investment trust reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.79 by $0.01, Zacks reports. Omega Healthcare Investors had a net margin of 46.83% and a return on equity of 10.72%.

Omega Healthcare Investors Stock Up 0.0%

Shares of OHI stock traded up $0.01 during mid-day trading on Wednesday, reaching $42.94. 2,787,649 shares of the company were exchanged, compared to its average volume of 2,012,638. The company has a market capitalization of $12.69 billion, a P/E ratio of 23.99, a P/E/G ratio of 1.39 and a beta of 0.57. The business’s 50 day simple moving average is $44.49 and its 200 day simple moving average is $42.58. The company has a debt-to-equity ratio of 0.95, a quick ratio of 7.11 and a current ratio of 7.11. Omega Healthcare Investors has a fifty-two week low of $35.04 and a fifty-two week high of $46.36.

Omega Healthcare Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, February 17th. Stockholders of record on Monday, February 9th will be given a dividend of $0.67 per share. The ex-dividend date of this dividend is Monday, February 9th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.2%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 149.72%.

Insider Buying and Selling

In other news, CIO Vikas Gupta purchased 11,500 shares of the company’s stock in a transaction that occurred on Thursday, November 6th. The shares were acquired at an average cost of $42.97 per share, with a total value of $494,155.00. Following the transaction, the executive owned 13,773 shares in the company, valued at approximately $591,825.81. The trade was a 505.94% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OHI. CIBC Private Wealth Group LLC grew its position in shares of Omega Healthcare Investors by 85.8% during the third quarter. CIBC Private Wealth Group LLC now owns 9,296 shares of the real estate investment trust’s stock worth $392,000 after acquiring an additional 4,292 shares during the last quarter. CIBC Bancorp USA Inc. acquired a new position in Omega Healthcare Investors during the 3rd quarter valued at about $3,273,000. Captrust Financial Advisors grew its position in Omega Healthcare Investors by 9.0% in the 3rd quarter. Captrust Financial Advisors now owns 63,922 shares of the real estate investment trust’s stock worth $2,699,000 after purchasing an additional 5,293 shares during the last quarter. Coldstream Capital Management Inc. grew its position in Omega Healthcare Investors by 2.4% in the 3rd quarter. Coldstream Capital Management Inc. now owns 62,382 shares of the real estate investment trust’s stock worth $2,634,000 after purchasing an additional 1,458 shares during the last quarter. Finally, Danske Bank A S bought a new stake in shares of Omega Healthcare Investors during the third quarter valued at approximately $84,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on OHI shares. The Goldman Sachs Group initiated coverage on shares of Omega Healthcare Investors in a report on Friday, January 9th. They set a “buy” rating and a $54.00 price objective on the stock. Weiss Ratings upgraded shares of Omega Healthcare Investors from a “buy (b+)” rating to a “buy (a-)” rating in a report on Monday, January 26th. UBS Group boosted their price objective on shares of Omega Healthcare Investors from $50.00 to $51.00 and gave the company a “buy” rating in a research note on Thursday, January 8th. Citigroup restated a “buy” rating and issued a $50.00 price target (up previously from $45.00) on shares of Omega Healthcare Investors in a report on Wednesday, November 12th. Finally, BMO Capital Markets downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “market perform” rating and set a $45.00 price objective for the company. in a research note on Friday, January 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $46.82.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.